Background: Antimutant activity of antimicrobials can be estimated by comparing drug pharmacokinetics with mutant prevention concentration (MPC). Large bacterial inocula known to reduce susceptibility have not been studied for effects on MPC determination.
Introduction
Controlling antimicrobial resistance is difficult, in part because subpopulations of resistant pathogens are selectively enriched by antimicrobials. Selective enrichment and amplification are proposed to occur when antimicrobial concentrations fall in a specific range called the mutant selection window. 1 The upper boundary of the selection window is the minimal concentration that blocks growth of the least susceptible, single-step resistant mutant subpopulation, a parameter termed the mutant prevention concentration (MPC). In principle, growth of resistant subpopulations is blocked by drug concentrations above MPC, just as susceptible growth is restricted by concentrations above MIC. Although agar-plate determinations of MPC can be used to define conditions that restrict mutant amplification when fluoroquinolone concentrations fluctuate, both in vitro and in vivo, 1 -3 the selection window hypothesis has not been tested for many antimicrobial -pathogen combinations.
Treatment of Staphylococcus aureus with daptomycin illustrates a potential problem for MPC determination. Daptomycin is a bactericidal 4 cyclic lipopeptide to which cells rarely exhibit resistance. 5, 6 However, 'false mutants' are readily recovered from daptomycin-containing agar. 6 'False mutants', which exhibit wild-type MIC, probably grow on daptomycin-containing agar because large bacterial inocula protect them from drug action. 6 Such protective inoculum effects make agar-based MPC determination difficult, as large numbers of bacterial cells (10 9 -10 10 ) must be applied to drug-containing plates.
The present work examined the effect of inoculum size on measurement of daptomycin MIC and MPC with S. aureus. remained a complex function of both inoculum size and drug concentration. Most of the inoculum effect was eliminated by measuring MPC using liquid medium.
Materials and methods
Strains, drugs and culture conditions S. aureus strain RN450, provided by Barry Kreiswirth (Public Health Research Institute), was stored at 2808C in CY medium, 7 supplemented with 15% glycerol. Daptomycin (Cubist Pharmaceuticals, Lexington, MA, USA) was dissolved in 0.9% NaCl to make 10 mg/mL stock solutions, which were diluted with molten MHA or Mueller -Hinton broth (MHB).
Susceptibility measurements
MIC was measured for 10 4 -10 5 cfu by broth dilution in MHB or by agar dilution on MHA, both supplemented with various concentrations of Ca 2þ . To measure apparent MPC with agar, S. aureus was grown overnight in CY medium 7 at 378C, washed three times with fresh CY, diluted 50-fold in fresh CY and grown to $10 9 cfu/mL. Cells were concentrated 10-fold by centrifugation and spread on daptomycincontaining MHA (supplemented with 0, 1 or 50 mM Ca 2þ ) at inoculum sizes ranging from 10 4 to 10 10 cfu. All plates were incubated at 378C for 48 h with assessment of colony number every 24 h.
MPC was measured in liquid medium by growth of cells to 10 9 cfu/mL in CY, dilution of 10 10 total cfu at various cell densities into MHB and treatment with various concentrations of daptomycin. The minimal daptomycin concentration that blocked growth of 10 10 total cells after 24 h of incubation was taken as MPC.
Characterization of daptomycin-resistant mutants
Putative mutants were passaged five times in drug-free MHB or on MHA before MIC was determined as above. Portions of mprF and yycG containing alleles implicated in daptomycin resistance 8 were amplified by PCR from chromosomal DNA using primers mprF-F1
0 -GGCGATGTACGTACGGTCGAT GTAACGA) and yycG-R(5 0 -ACGTCCACGGCGGTCTGTTGCA). Nucleotide sequences were determined using primers mprF-S1 (5 0 -G CTTTATTCCTGGTGGTTTCGGCGCT), mprF-S2 (5 0 -CGACTTGC AGGCCGTGTCTTTGAAC) and yycG-S (5 0 -TGGCGGTGGTAAG GACCGTGTCTG). When S. aureus was applied to agar, supplemented with either 1 or 50 mM CaCl 2 plus various concentrations of daptomycin, increasing inoculum size increased colony number more than expected (non-proportional recovery, e.g. a 10-fold increase in bacterial load caused colony number to increase 50-fold or more). Such an inoculum effect could not be eliminated by increasing CaCl 2 supplementation to 50 mM. Proportional recovery of individual colonies did occur within a narrow ($10-fold) inoculum range that was shifted upward as daptomycin concentration increased (shown by vertical lines connecting symbols in Figure 1a and b). The number of individual colonies observed under proportional recovery conditions provided apparent population analysis profiles for daptomycin with 1 and 50 mM Ca 2þ supplementation (Figure 1c and d) . The profiles were roughly parallel, with inhibition of colony formation occurring at a lower daptomycin concentration for 50 mM Ca 2þ than for 1 mM Ca 2þ . MPC (no colony formation with 10 10 cells tested 1 ) could only be estimated by extrapolation. Two independent estimates of MPC at 1 mM Ca 2þ and three estimates at 50 mM Ca 2þ averaged 20 and 3 mg/L, respectively.
Results

Effect of
Determination of MPC with liquid medium
Uncertainties associated with extrapolation prompted us to develop an alternate measure of MPC. S. aureus cultures were grown in liquid medium to 10 9 cfu/mL, and they were diluted in MHB at various cell densities so total cell number was $10 10 cfu (5-12 Â 10 9 ). Daptomycin concentrations that blocked subsequent growth, as judged by the lack of increase in culture turbidity following a 24 h incubation, were defined as MPC. MPC, determined with 10 7 cfu/mL in 1 L of MHB supplemented with 1 mM Ca 2þ , was between 2.5 (three determinations) and 5 mg/L (two determinations). When 10 10 cells were tested at 5 Â 10 7 and 2.5 Â 10 8 cfu/mL (200 and 40 mL, respectively), MPC was higher (10 and 20 mg/L, respectively). Thus cell density also affected MPC determination using liquid medium.
Characterization of putative mutants
Ten independent colonies, obtained from daptomycin-containing agar supplemented with either 1 or 50 mM CaCl 2 , were passaged five times on drug-free agar before testing for MIC at each Ca 2þ concentration. MIC was the same as with the parental strain, i.e. the colonies comprised 'false mutants'. 6 With 1 L liquid cultures (10 7 cfu/mL), cells recovered from the highest drug concentration allowing growth were passaged five times as bulk subcultures in drug-free MHB ( passages preceded by 1:1000 dilutions). After passage, these subcultures exhibited an 8-fold increase in MIC 99 (minimal concentration reducing colony formation on MHA by 99%). With batch subcultures, increasing daptomycin concentration in agar from 2Â to 8Â MIC 99 decreased the number of colonies gradually; thus, these cultures contained multiple mutant types having various levels of susceptibility. With homogeneous cultures prepared after purifying batch subcultures to single colonies on agar, daptomycin MIC and MIC 99 increased by 4-and 8-fold, respectively. When three independent mutants were analysed for variations in mprF and yycG, genes previously implicated in daptomycin resistance with serially passaged and clinical samples, 8 one mutant contained a previously reported 8 serine to leucine change at position 295 of MprF and two mutants contained a new mprF daptomycin-resistant allele (Ser-337!Leu). No change was found in YccG. Thus, the primary determinant for daptomycin resistance maps to mprF.
Discussion
A complex relationship exists between bacterial inoculum size, daptomycin concentration and formation of individual colonies on agar. Agar-plate determination of MPC, which required extrapolation of population analysis curves, produced values of 10 -20 mg/L at 1 mM Ca 2þ . These values fit with those obtained previously using several other strains of S. aureus.
9 Inoculum effects, plus the inability to recover bona fide mutants, indicate that agar-plate determinations overestimated MPC. Liquid assays allowed the use of lower inoculum densities, which explains liquid-determined MPC (2.5-5 mg/L at 1 mM Ca 2þ ) being lower than agar-determined values. Inoculum effects also caused liquid assays to overestimate MPC. However, the overestimate was 2-fold or less when determined with 10 7 cfu/mL cultures, as mutants recovered had MIC values of 1.28 -2.56 mg/L, about half the measured MPC (MPC can be defined as MIC for the least susceptible single-step mutant).
With humans, daptomycin pharmacokinetics determined with 4 mg/kg doses administered once daily indicates that minimal serum concentrations of daptomycin are $6 mg/L, 4 which is higher than MPC (2.5 -5 mg/L). With the higher approved dose (6 mg/kg), peak serum concentration is $100 mg/L and half-life is $9 h. 10 In this situation, even after taking into account 90% protein binding, 4 plasma daptomycin concentration should be above MPC for most of the 24 h dosing interval. These considerations are consistent with resistance arising rarely during daptomycin treatment.
5,6
Although we did not recover bona fide resistant mutants from agar-plate assays, they can be obtained in liquid by serial passage. 8 Such mutants explain the increase in MIC observed by Firsov et al. 9 when S. aureus is challenged with moderate concentrations of daptomycin using a dynamic model. No MIC increase was observed when concentrations were kept above MPC, as expected when selective amplification of mutants is prevented. 9 We obtained daptomycin-resistant mutants containing variations in MprF by a single challenge using a large volume of low-density liquid cultures. To the best of our knowledge, this is the first report of single-challenge recovery of daptomycin-resistant mutants.
We conclude that MPC can be determined using liquid assays even when inoculum effects occur. The present study, plus work by Firsov et al., 9 show that the mutant selection window hypothesis applies to antimicrobials other than fluoroquinolones.
